MX2009011595A - Novedosas moleculas de anticuerpos y acidos nucleicos que se enlazan con la proteina de tension fungica hsp90. - Google Patents
Novedosas moleculas de anticuerpos y acidos nucleicos que se enlazan con la proteina de tension fungica hsp90.Info
- Publication number
- MX2009011595A MX2009011595A MX2009011595A MX2009011595A MX2009011595A MX 2009011595 A MX2009011595 A MX 2009011595A MX 2009011595 A MX2009011595 A MX 2009011595A MX 2009011595 A MX2009011595 A MX 2009011595A MX 2009011595 A MX2009011595 A MX 2009011595A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acids
- antibody molecules
- stress protein
- novel antibody
- protein hsp90
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se da a conocer un péptido scFv, el cual comprende un dominio VH y un dominio VL enlazados por un espaciador de aminoácidos. El dominio VH comprende una secuencia con una identidad de secuencia de cuando menos el 80 por ciento con la secuencia de la SEQ ID NO:64. El dominio VL comprende una secuencia con una identidad de secuencia de cuando menos el 80 por ciento con la secuencia de la SEO ID NO:66. El péptido scFv también comprende la sustitución o la supresión de un aminoácido en el dominio VH en la posición correspondiente a C28.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07107140 | 2007-04-27 | ||
EP07113353 | 2007-07-27 | ||
PCT/EP2008/055006 WO2008132134A1 (en) | 2007-04-27 | 2008-04-24 | Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011595A true MX2009011595A (es) | 2009-12-08 |
Family
ID=39717534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011595A MX2009011595A (es) | 2007-04-27 | 2008-04-24 | Novedosas moleculas de anticuerpos y acidos nucleicos que se enlazan con la proteina de tension fungica hsp90. |
Country Status (21)
Country | Link |
---|---|
US (3) | US20100113355A1 (es) |
EP (2) | EP2144932A1 (es) |
JP (1) | JP2010524485A (es) |
KR (1) | KR20100017387A (es) |
CN (1) | CN101679517A (es) |
AR (1) | AR066311A1 (es) |
AU (1) | AU2008244308A1 (es) |
BR (1) | BRPI0810827A2 (es) |
CA (1) | CA2685136A1 (es) |
CL (1) | CL2008001202A1 (es) |
CR (1) | CR11059A (es) |
EA (1) | EA200901441A1 (es) |
EC (1) | ECSP099765A (es) |
GT (1) | GT200900276A (es) |
IL (1) | IL201445A0 (es) |
MA (1) | MA31384B1 (es) |
MX (1) | MX2009011595A (es) |
PE (1) | PE20090728A1 (es) |
TN (1) | TN2009000442A1 (es) |
TW (1) | TW200902714A (es) |
WO (2) | WO2008132152A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100113355A1 (en) | 2007-04-27 | 2010-05-06 | Naresh Chennamsetty | Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
AU2015292498B2 (en) * | 2014-07-23 | 2020-11-05 | Ohio State Innovation Foundation | Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72) |
CN105652011B (zh) * | 2014-11-20 | 2017-09-22 | 深圳市安群生物工程有限公司 | 检测人HSP90α‑2蛋白的荧光免疫层析试纸及其制备方法 |
CN113845591B (zh) * | 2018-10-30 | 2023-10-31 | 迈威(上海)生物科技股份有限公司 | Hsp90抗体及其在抗真菌感染中的应用 |
WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732852A (en) | 1981-11-20 | 1988-03-22 | Cetus Corporation | Site directed peptidase cleavage |
US4670382A (en) | 1983-12-02 | 1987-06-02 | Temple University--of the Commonwealth System of Higher Education | Monoclonal antibody to Candida albicans cytoplasmic antigens and methods of preparing same |
US4806465A (en) | 1984-01-16 | 1989-02-21 | Temple University Of The Commonwealth System Of Higher Education | Cytoplasmic antigens of candida albicans and methods of using the same |
GB8506373D0 (en) | 1985-03-12 | 1985-04-11 | Axon Healthcare Ltd | Antigens antibodies |
GB8915019D0 (en) | 1989-06-30 | 1989-08-23 | Matthews Ruth C | Medicaments |
EP0861893A3 (en) | 1991-09-19 | 1999-11-10 | Genentech, Inc. | High level expression of immunoglobulin polypeptides |
GB2270076A (en) | 1992-08-18 | 1994-03-02 | Univ Manchester | Human HSP 90 Epitopes |
AU769235B2 (en) | 1999-04-09 | 2004-01-22 | Sloan-Kettering Institute For Cancer Research | Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases |
ATE361313T1 (de) | 2000-01-25 | 2007-05-15 | Oklahoma Med Res Found | Allgemeines verfahren zur rückfaltung rekombinanter proteine |
GB0008305D0 (en) * | 2000-04-06 | 2000-05-24 | Neutec Pharma Plc | Treatment of fungal infections |
AU2001272001A1 (en) | 2000-07-14 | 2002-01-30 | Healthcite, Inc. | Method and system for providing medical information |
AU2002252179A1 (en) * | 2001-03-01 | 2002-09-19 | Conforma Therapeutics Corp. | Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
GB0127983D0 (en) | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
GB0315111D0 (en) * | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
GB0409077D0 (en) * | 2004-04-23 | 2004-05-26 | Neutec Pharma Plc | Treatment of fungal infections |
US20080038267A1 (en) * | 2004-07-02 | 2008-02-14 | Neutec Pharma Limited | Treatment Of Cancer |
US20100113355A1 (en) | 2007-04-27 | 2010-05-06 | Naresh Chennamsetty | Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
WO2008132174A1 (en) | 2007-04-27 | 2008-11-06 | Novartis Ag | An immunoglobulin composition |
-
2006
- 2006-04-24 US US12/597,229 patent/US20100113355A1/en not_active Abandoned
-
2008
- 2008-04-24 EP EP08736541A patent/EP2144932A1/en not_active Withdrawn
- 2008-04-24 WO PCT/EP2008/055037 patent/WO2008132152A1/en active Application Filing
- 2008-04-24 KR KR1020097024646A patent/KR20100017387A/ko not_active Application Discontinuation
- 2008-04-24 BR BRPI0810827-7A2A patent/BRPI0810827A2/pt not_active Application Discontinuation
- 2008-04-24 EA EA200901441A patent/EA200901441A1/ru unknown
- 2008-04-24 CN CN200880013913A patent/CN101679517A/zh active Pending
- 2008-04-24 CA CA002685136A patent/CA2685136A1/en not_active Abandoned
- 2008-04-24 WO PCT/EP2008/055006 patent/WO2008132134A1/en active Application Filing
- 2008-04-24 AU AU2008244308A patent/AU2008244308A1/en not_active Abandoned
- 2008-04-24 US US12/150,076 patent/US7722869B2/en not_active Expired - Fee Related
- 2008-04-24 JP JP2010504689A patent/JP2010524485A/ja active Pending
- 2008-04-24 MX MX2009011595A patent/MX2009011595A/es unknown
- 2008-04-24 EP EP08749716A patent/EP2152746A1/en not_active Withdrawn
- 2008-04-25 TW TW097115380A patent/TW200902714A/zh unknown
- 2008-04-25 PE PE2008000709A patent/PE20090728A1/es not_active Application Discontinuation
- 2008-04-25 CL CL2008001202A patent/CL2008001202A1/es unknown
- 2008-04-25 AR ARP080101768A patent/AR066311A1/es unknown
-
2009
- 2009-10-09 CR CR11059A patent/CR11059A/es not_active Application Discontinuation
- 2009-10-11 IL IL201445A patent/IL201445A0/en unknown
- 2009-10-23 GT GT200900276A patent/GT200900276A/es unknown
- 2009-10-23 TN TNP2009000442A patent/TN2009000442A1/fr unknown
- 2009-11-20 MA MA32355A patent/MA31384B1/fr unknown
- 2009-11-27 EC EC2009009765A patent/ECSP099765A/es unknown
-
2010
- 2010-03-08 US US12/719,049 patent/US20100166758A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2152746A1 (en) | 2010-02-17 |
IL201445A0 (en) | 2010-06-16 |
ECSP099765A (es) | 2009-12-28 |
CL2008001202A1 (es) | 2008-12-19 |
WO2008132134A1 (en) | 2008-11-06 |
JP2010524485A (ja) | 2010-07-22 |
KR20100017387A (ko) | 2010-02-16 |
CA2685136A1 (en) | 2008-11-06 |
BRPI0810827A2 (pt) | 2014-10-29 |
US20100113355A1 (en) | 2010-05-06 |
CR11059A (es) | 2009-11-20 |
AU2008244308A1 (en) | 2008-11-06 |
US20100166758A1 (en) | 2010-07-01 |
TN2009000442A1 (en) | 2011-03-31 |
WO2008132152A1 (en) | 2008-11-06 |
AR066311A1 (es) | 2009-08-12 |
US7722869B2 (en) | 2010-05-25 |
EA200901441A1 (ru) | 2010-04-30 |
PE20090728A1 (es) | 2009-07-02 |
TW200902714A (en) | 2009-01-16 |
EP2144932A1 (en) | 2010-01-20 |
US20090136484A1 (en) | 2009-05-28 |
CN101679517A (zh) | 2010-03-24 |
GT200900276A (es) | 2010-05-21 |
WO2008132134A9 (en) | 2009-07-09 |
MA31384B1 (fr) | 2010-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2987806A3 (en) | Modified single variable domain antibodies with reduced binding to anti-drug-antibodies | |
NZ597692A (en) | Anti-IGF antibodies | |
NZ612319A (en) | Single-chain multivalent binding proteins with effector function | |
TN2009000442A1 (en) | Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 | |
NZ601615A (en) | Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor | |
NZ701769A (en) | Coiled coil and/or tether containing protein complexes and uses thereof | |
EP3683312A3 (en) | Synthetic library of specific binding molecules | |
WO2005051998A3 (en) | Antibodies binding to a c-terminal fragment of apolipoprotein e | |
PE20120001A1 (es) | Dominios variables simples anti-albumina de suero mejorados | |
WO2008114149A3 (en) | Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains | |
NZ600278A (en) | Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto | |
NZ587198A (en) | Monoclonal antibodies against the rgm a protein and uses thereof | |
RS52790B (en) | MONOCLONAL ANTIBODIES AGAINST CLAUDINE-18 FOR THE CANCER TREATMENT | |
WO2008048545A3 (en) | Molecules with reduced half-lives, compositions and uses thereof | |
MXPA04008077A (es) | Anticuerpos ant-a° y su uso. | |
WO2009004822A1 (ja) | 抗Muc17抗体 | |
WO2014090905A8 (en) | Modified coiled coil type proteins having improved properties | |
MX2010000994A (es) | Dominio vhh monomerico derivado de anticuerpos de camelidos anti-vp6, dominio dimerico, metodo de inmunizacion, metodo de deteccion de rotavirus, composicion, metodos de prevencion y tratamiento de infecciones con rotavirus. | |
WO2008039838A3 (en) | Synthetic streptococcus pneumoniae vaccine | |
WO2008142664A3 (en) | Exposed thymidine kinase 1 peptides, ligands and methods employing the same | |
WO2004108749A3 (en) | Binding peptides: methods for their generation and use | |
DK1913020T3 (da) | Immunogene konstrukter | |
AR082160A1 (es) | Anticuerpos monoclonales dirigidos contra la toxina tetanica | |
ATE490270T1 (de) | Zytokinderivate | |
WO2009060710A1 (ja) | リポソームに抗体結合能を付与するペプチド、および当該ペプチドで修飾されたリポソーム |